Furthermore, we examined the expression levels of two tumor vasculature markers, CD31 and CD105, in xenograft tumors formed by CRC cells with stable knockdown or overexpression of ELK4 by IHC staining to confirm the role of ELK4 in tumor angiogenesis in vivo. This evidence concerns the gene ELK4 and neoplasm.